Company intelligence / Profile preview

PromptBio

Pleasanton, California, United Statespromptbio.ai ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

PromptBio provides an automated, AI-driven software solution that streamlines the process of discovering, accessing, integrating, processing, and analyzing public biological datasets. The platform offers validated pipelines for standard assays—including those from nf-core—and integrates GPU acceleration via NVIDIA Parabricks. It uses NLP/LLMs to extract disease marker associations from literature rapidly. The system is designed to accelerate biomarker discovery with high reliability by automating workflows that traditionally require significant manual effort.

Therapeutic areas: Other
Modalities: biomarkersomics datadisease markers
Industry: Drug Discovery Services

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on PromptBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PromptBio.

Explore the full profile